Stay informed with the latest litigation news. Explore now

IP Verse

Mylan competitive analysis

Latest publications and patents of Mylan New

Explore the latest publications and patents granted to Mylan, showcasing their recent innovations and technological advancements.

Last updated on: Sep 3, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Mylan

EP2299989
Jan 2, 2019Stabilized Transdermal Drug Delivery SystemOpposition Rejected
EP2702143
Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing PolypeptideRevoked
EP2682388
Jan 10, 2018Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation ThereofRevoked
EP2016025634
Feb 18, 2016Medicament Information System And Method -

Latest oppositions filed by Mylan

Explore patent oppositions filed by Mylan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
EP2785702
Crystalline Dapagliflozin HydrateSANDOZOct 22, 2020
EP2371361
Methods To Mobilize Progenitor/Stem CellsGENZYMEMay 4, 2020
EP2630962
Low Frequency Glatiramer Acetate TherapyYEDA RESEARCHMar 25, 2019
EP3199172
Dosing Regimen For Multiple SclerosisYEDA RESEARCHMar 25, 2019
EP2420223
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHApr 19, 2018
EP3000810
N3 Alkylated Benzimidazole Derivative As Mek InhibitorARRAY BIOPHARMAApr 19, 2018
EP2308466
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHFeb 28, 2018
EP3042646
Pharmaceutical Compositions Having Desirable BioavailabilityALCON RESEARCHFeb 9, 2018
EP2599475
Pharmaceutical Composition Having Desirable BioavailabilityALCON RESEARCHJan 26, 2018

Latest patents of Mylan opposed by its competitors

Explore Mylan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2299989
Jan 2, 2019Stabilized Transdermal Drug Delivery System1
EP2702143
Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing Polypeptide1
EP2682388
Jan 10, 2018Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof2

Latest PTAB cases involving Mylan New

Discover the latest PTAB cases involving Mylan, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 9, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Mylan

IPR2023-00724Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKTerminated-Settled
IPR2023-00722Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2023-00723Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2023-00099Oct 28, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSInstitution Denied
IPR2022-01226Jul 1, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSFinal Written Decision
IPR2022-01225Jul 1, 2022MYLAN PHARMACEUTICALSREGENERON PHARMACEUTICALSFinal Written Decision
IPR2022-01102Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01103Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01104Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied
IPR2022-01105Jun 10, 2022MYLAN PHARMACEUTICALSBAUSCH HEALTH IRELANDInstitution Denied

Top competitors of Mylan

Top competitors of Mylan based on patent oppositions.